Stimuli-sensitive nanopreparations for combination cancer therapy
Nanocarriers have revolutionized drug delivery practices over the past couple of decades,
primarily due to the advances in materials chemistry, nanotechnology and nanomedicine …
primarily due to the advances in materials chemistry, nanotechnology and nanomedicine …
Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents
Nanoparticles (NPs) have been extensively investigated for applications in both
experimental and clinical settings to improve delivery efficiency of therapeutic and …
experimental and clinical settings to improve delivery efficiency of therapeutic and …
Multifunctional nanomaterials and their applications in drug delivery and cancer therapy
M Srinivasan, M Rajabi, SA Mousa - Nanomaterials, 2015 - mdpi.com
The field of nanotechnology has led to the development of many innovative strategies for
effective detection and treatment of cancer, overcoming limitations associated with …
effective detection and treatment of cancer, overcoming limitations associated with …
Recent development of synthetic nonviral systems for sustained gene delivery
Highlights•Summary of recent significant research on developing revolutionary sustained
gene delivery carriers.•Synthetic nonviral systems have innate biocompatibility and tunable …
gene delivery carriers.•Synthetic nonviral systems have innate biocompatibility and tunable …
[HTML][HTML] Rational design and latest advances of codelivery systems for cancer therapy
QY Meng, HL Cong, H Hu, FJ Xu - Materials Today Bio, 2020 - Elsevier
Current treatments have limited effectiveness in treating tumors. The combination of multiple
drugs or treatment strategies is widely studied to improve therapeutic effect and reduce …
drugs or treatment strategies is widely studied to improve therapeutic effect and reduce …
Polymer assembly: Promising carriers as co-delivery systems for cancer therapy
N Li, L Zhao, L Qi, Z Li, Y Luan - Progress in Polymer Science, 2016 - Elsevier
Drug-delivery systems, including liposomes, polymeric micelles, polymersomes, hydrogels
and other formulations, have attracted much attention in recent years because they can …
and other formulations, have attracted much attention in recent years because they can …
Sustained delivery of doxorubicin from thermogelling poly (PEG/PPG/PTMC urethane) s for effective eradication of cancer cells
XJ Loh, W Guerin, SM Guillaume - Journal of Materials Chemistry, 2012 - pubs.rsc.org
A series of multiblock poly (ether carbonate urethane) s comprising poly (trimethylene
carbonate), poly (ethylene glycol), and poly (propylene glycol) segments, with a molecular …
carbonate), poly (ethylene glycol), and poly (propylene glycol) segments, with a molecular …
Novel chitosan derivatives with reversible cationization and hydrophobicization for tumor cytoplasm-specific burst co-delivery of siRNA and chemotherapeutics
T Yin, Y Liu, M Yang, L Wang, J Zhou… - ACS applied materials & …, 2020 - ACS Publications
Despite the great potential of combination therapy based on siRNA and chemotherapeutics,
an efficient vehicle with abilities of well drug co-loading, synchronizing in vivo trafficking, and …
an efficient vehicle with abilities of well drug co-loading, synchronizing in vivo trafficking, and …
Smart stimuli-responsive nanocarriers for the cancer therapy–nanomedicine
Nanomedicine is ongoing current research in the applications of nanotechnology for cancer
therapy. Simply from a technology perspective, this field of research has an enormous …
therapy. Simply from a technology perspective, this field of research has an enormous …
Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer
M Uz, M Kalaga, R Pothuraju, J Ju, WM Junker… - Journal of Controlled …, 2019 - Elsevier
A polymeric dual delivery nanoscale device (DDND) was designed for combined delivery of
microRNA (miR-345) and gemcitabine (GEM) to treat pancreatic cancer (PC). This …
microRNA (miR-345) and gemcitabine (GEM) to treat pancreatic cancer (PC). This …